EFPIA Newsletter 30 April 2026

Blogs     30 April 2026 EU Biotech Act: how to turn innovation into impact (Guest blog) Innovative biotechnologies bring real promise for patients in Europe, but they are complex to develop, test, and manufacture.... Read more →

Europe’s Choice: The value of investing in innovation

Europe stands at a crossroads. In a world shaped by geopolitical tensions, economic fragmentation and accelerating global competition, the choices made today will determine Europe’s ability to compete, innovate and lead in the decades ahead.  Join us on 23 June in Brussels to engage in a forward-looking discussion on how Europe can turn today’s challenges into opportunities – and make the right choices for its future.  Register here.

Events     07 MAY 2026   Towards comprehensive cardiovascular health checks across Europe Brussels, Belgium Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity in Europe, despite significant advances... Learn more →       08 MAY 2026   Unlocking Europe’s Life Science potential: A policy agenda for competitiveness, innovation... The Landmark Nicosia, Cyprus Europe stands at a critical moment for its life sciences sector. Across the world, governments are actively strengthening... Learn more →

	19 MAY 2026			European Pharmaceutical Law Forum Brussels, Belgium The European pharmaceutical market is facing a moment of profound change. With sweeping updates to the EU pharmaceutical... Learn more →

	17 JUN 2026			Inaugural Forum on Life Sciences Product Liability, Policy & Dispute Resolution Europe... Brussels, Belgium The must-attend European defense strategy forum for the life sciences litigation community. Europe’s Premier Forum for... Learn more →

What we are reading Shielding Europe against vaccine-preventable cancers 24 April 2026  (Vaccines Today) Read more → History of vaccines 20 April 2026  (University of Oxford) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe